Concerns persist about TNF inhibitor melanoma risk
30th August 2017
By Clare Pain
Australian cancer experts say it is too early to dismiss concerns about melanoma risk in rheumatoid arthritis (RA) patients treated with biologics, despite an apparent “all clear” from European data.